<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04621175</url>
  </required_header>
  <id_info>
    <org_study_id>20-14HC</org_study_id>
    <nct_id>NCT04621175</nct_id>
  </id_info>
  <brief_title>Effects of Essential Amino Acid-enriched Whey and Carbohydrate Co-ingestion on Protein Kinetics</brief_title>
  <official_title>Determining Optimal Energy Substrate to Enhance Postprandial Protein Kinetic Responses to Essential Amino Acid-enriched Whey During Energy Deficit</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>United States Army Research Institute of Environmental Medicine</agency>
      <agency_class>U.S. Fed</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University of Arkansas</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Eastern Michigan University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>United States Army Research Institute of Environmental Medicine</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Previous work conducted by the Investigators demonstrates that an essential amino&#xD;
      acid(EAA)-enriched whey protein combination format is an efficient EAA/protein format to&#xD;
      support enhanced whole-body protein balance and sustain muscle protein synthesis compared to&#xD;
      isonitrogenous amounts of whey alone or a mixed-macronutrient meal. However, additional work&#xD;
      is needed to optimize the formulation to ensure the best possible muscle and whole-body&#xD;
      anabolic responses are achieved. This includes addressing the potential value of adding&#xD;
      non-EAA/protein components to support energy demands. Providing additional non-protein energy&#xD;
      to an EAA-enriched whey protein formulation may reduce the proportion of exogenous amino&#xD;
      acids directed towards energy production thereby preserving its use for muscle protein&#xD;
      synthesis. However, whether suppressing exogenous amino acid oxidation by providing&#xD;
      additional carbohydrate allows for a greater muscle protein synthetic stimulus during&#xD;
      moderate energy deficit (- 30% total energy requirements) is unknown. Therefore, this study&#xD;
      will test the effects of EAA-enriched whey protein plus carbohydrate versus EAA-enriched whey&#xD;
      plus additional EAA using a randomized, cross-sectional longitudinal study design.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In this study the Investigators will test the effects of EAA-enriched whey protein plus&#xD;
      carbohydrate versus EAA-enriched whey plus additional EAA using a randomized, cross-sectional&#xD;
      longitudinal study design. Thirty healthy, functional and aerobic exercise trained adults&#xD;
      will complete two, 5-d controlled feeding phases, one maintaining energy balance and one&#xD;
      inducing energy deficit in random order and separated by at least a 7d washout period. The&#xD;
      difference in post-exercise (whole-body exercise model) muscle protein synthesis and&#xD;
      whole-body protein turnover between the study treatments will be determined the day after&#xD;
      each 5-d controlled feeding phase. This design will test the following hypotheses: 1) The&#xD;
      magnitude of post-exercise anabolic response to EAA-enriched whey protein plus carbohydrate&#xD;
      are enhanced compared to EAA-enriched whey protein plus additional EAA during energy deficit;&#xD;
      2) Regardless of protein treatment, the magnitude of anabolic response will be reduced during&#xD;
      energy deficit compared to energy balance.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 9, 2020</start_date>
  <completion_date type="Anticipated">September 2021</completion_date>
  <primary_completion_date type="Anticipated">September 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>randomized, cross-sectional, longitudinal study</intervention_model_description>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
    <masking_description>double (participant and investigator)</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Whole-body Protein Balance</measure>
    <time_frame>approximately 5.75 hours</time_frame>
    <description>Whole-body net balance will be determined using stable-isotope methodologies</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Whole-body Protein Synthesis</measure>
    <time_frame>approximately 5.75 hours</time_frame>
    <description>Whole-body protein synthesis will be determined using stable-isotope methodologies</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Whole-body Protein Breakdown</measure>
    <time_frame>approximately 5.75 hours</time_frame>
    <description>Whole-body protein breakdown will be determined using stable-isotope methodologies</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Muscle Protein Synthesis</measure>
    <time_frame>approximately 5.75 hours</time_frame>
    <description>Muscle protein synthesis will be determined using stable-isotope methodologies</description>
  </primary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Energy Deficit</condition>
  <arm_group>
    <arm_group_label>EAA+W &amp; Carbohydrate: Balance (BAL) first, then Deficit (DEF)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Participants will consume an essential amino acid plus whey (EAA+W) beverage with added Carbohydrate during energy balance (BAL) first, then again during energy deficit (DEF).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>EAA+W &amp; Carbohydrate: DEF first, then BAL</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Participants will consume an essential amino acid plus whey beverage with added Carbohydrate during energy deficit first, then again during energy balance.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>EAA+W &amp; EAA: BAL first, then DEF</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Participants will consume an essential amino acid (EAA) plus whey beverage with added EAA during energy balance first, then again during energy deficit.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>EAA+W &amp; EAA: DEF first, then BAL</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Participants will consume an essential amino acid (EAA) plus whey beverage with added EAA during energy deficit first, then again during energy balance.</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>EAA+W &amp; Carbohydrate</intervention_name>
    <description>Essential amino acid plus whey beverage with added carbohydrate</description>
    <arm_group_label>EAA+W &amp; Carbohydrate: Balance (BAL) first, then Deficit (DEF)</arm_group_label>
    <arm_group_label>EAA+W &amp; Carbohydrate: DEF first, then BAL</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>EAA+W &amp; EAA</intervention_name>
    <description>Essential amino acid plus whey beverage with added essential amino acid</description>
    <arm_group_label>EAA+W &amp; EAA: BAL first, then DEF</arm_group_label>
    <arm_group_label>EAA+W &amp; EAA: DEF first, then BAL</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Body mass index &lt; 30.0 kg/m2&#xD;
&#xD;
          -  Weight stable in the past 2 months (± 2.27 kg)&#xD;
&#xD;
          -  Healthy without evidence of chronic illness or musculoskeletal injury as determined by&#xD;
             the USARIEM Office of Medical Support and Oversight (OMSO) or home duty station&#xD;
             medical support&#xD;
&#xD;
          -  Functional exercise (i.e., step ups, box jumps, body mass movements) and/or aerobic&#xD;
             exercise trained defined by self-report as performing ≥ 2 sessions/wk for previous 6&#xD;
             months&#xD;
&#xD;
          -  Willing to refrain from taking any nonsteroidal anti-inflammatory drugs (e.g.,&#xD;
             aspirin, Advil®, Aleve®, Naprosyn®), or any other aspirin-containing product for 10&#xD;
             days before the first ~8.5 hour laboratory day and at least 5 days after completing&#xD;
             the last ~8.5 hour laboratory day&#xD;
&#xD;
          -  Willing to refrain from alcohol, smoking any nicotine product (includes e-cigarettes),&#xD;
             vaping, chewing tobacco, caffeine, and dietary supplements after the completing the&#xD;
             baseline period until the end of the study&#xD;
&#xD;
          -  Must obtain supervisor approval for federal civilian employees and non-HRV active duty&#xD;
             military personnel working within the US Army Natick Soldier Systems Center&#xD;
&#xD;
          -  Females must have normal menstrual cycles between 26-32 days in duration; 5 menstrual&#xD;
             cycles within the past 6 months; or able to provide documentation of oral/hormonal&#xD;
             contraceptive use which contains low-dose estrogen/progesterone to maintain continuous&#xD;
             levels throughout the 28-day cycle (i.e., no placebos)&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Metabolic or cardiovascular abnormalities, gastrointestinal disorders (e.g., kidney&#xD;
             disease, diabetes, cardiovascular disease, etc.)&#xD;
&#xD;
          -  Abnormal PT/PTT test or problems with blood clotting&#xD;
&#xD;
          -  History of complications with lidocaine&#xD;
&#xD;
          -  Present condition of alcoholism, anabolic steroids, or other substance abuse issues as&#xD;
             assessed by OMSO&#xD;
&#xD;
          -  Participation in blood donation within 8-wk of beginning the study&#xD;
&#xD;
          -  Pregnant, trying to become pregnant, and/or breastfeeding (results of urine pregnancy&#xD;
             test or self-report for breastfeeding will be obtained before body composition&#xD;
             testing)&#xD;
&#xD;
          -  Unwillingness or inability to consume study diets or foods provided due to personal&#xD;
             preference, dietary restrictions, and/or food allergies&#xD;
&#xD;
          -  Unwillingness to adhere to study physical restrictions&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>35 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jess A Gwin, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>US Army Research Institute of Environmental Medicine</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Jess A Gwin, PhD</last_name>
    <phone>508-206-2300</phone>
    <email>jessica.a.gwin.ctr@mail.mil</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Jillian T Allen, MS, RD</last_name>
    <phone>508-206-2172</phone>
    <email>jillian.t.allen.ctr@mail.mil</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>US Army Research Institute of Environmental Medicine</name>
      <address>
        <city>Natick</city>
        <state>Massachusetts</state>
        <zip>01760</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jess Gwin, PhD</last_name>
      <phone>508-206-2300</phone>
      <email>jessica.a.gwin.ctr@mail.mil</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>November 2020</verification_date>
  <study_first_submitted>August 24, 2020</study_first_submitted>
  <study_first_submitted_qc>November 2, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">November 9, 2020</study_first_posted>
  <last_update_submitted>November 24, 2020</last_update_submitted>
  <last_update_submitted_qc>November 24, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">November 30, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>whole-body protein turnover</keyword>
  <keyword>muscle protein synthesis</keyword>
  <keyword>protein kinetics</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

